How do I get treatment?

For further information and appointments please contact us on:

0207 881 2020

The Team

  • Professor Loïc Lang-Lazdunski, MD, PhD, FRCS (Eng), Consultant Thoracic Surgeon

    Loic Lang-Lazdunski

    Professor Loïc Lang-Lazdunski was born in France, he graduated from Xavier Bichat Medical School, Paris in 1991 and trained in General Surgery and Cardiothoracic Surgery in Paris. He was awarded an MD in 1996 and a PhD in experimental surgery in 2000.

    He spent a year working as a post-doctoral research fellow at Harvard Medical School / Massachusetts General Hospital and was a visiting fellow at several prestigious cardiothoracic units including Massachusetts General Hospital, Brigham and Women Hospital, in Boston and Methodist Hospital-Baylor College of Medicine, Houston to get additional training in Thoracic Surgical Oncology.

    He was appointed as Assistant Professor of Cardiothoracic Surgery at Paris University in November 1998 and held consultant positions in two major university hospitals in Paris until 2002. He was appointed a Consultant Thoracic Surgeon at Guy’s and St Thomas’ Hospital NHS Foundation Trust in 2003. He was promoted to Professor of Thoracic Surgery at King’s College, London in 2012.

    Mr Lang-Lazdunski has a special interest in malignant pleural mesothelioma, lung cancer and other thoracic malignancies. He has led the program in malignant pleural mesothelioma at Guy’s Hospital, one of the busiest in Europe, since his appointment.

    He has an interest in extended resections for advanced-stage lung cancer including tracheal resections, great vessels resections and major chest wall resections, and also mediastinal tumours such as thymomas or germ cell tumours.

    He has developed a large activity in the field of lung resection and metastasectomy for secondary lung cancer. Mr Lang-Lazdunski is a recognised expert in minimally invasive and Video-Assisted Thoracic Surgery (VATS) and has developed a program of VATS lobectomy and segmentectomy for early stage lung cancer and VATS resection of mediastinal tumours at Guy’s Hospital. Mr Lang-Lazdunski has an interest in congenital chest wall malformations, tumours and infections in children and adults.

    He is involved in clinical and basic research in the field of malignant mesothelioma, lung cancer and other thoracic malignancies. He is an investigator or principal investigator in several international trials in the field of mesothelioma or lung cancer.

    He has published more than 100 scientific articles in the field of cardiothoracic surgery and has made many presentations at national and international meetings. He is a regular reviewer for the Journal of Thoracic and Cardiovascular Surgery, the Annals of Thoracic Surgery and the European Journal of Cardiothoracic Surgery and serves on several national and international scientific committees.

    Mr Loïc Lang-Lazdunski is an active member of several learned societies including the European Association for Cardiothoracic Surgery, the Society of Thoracic Surgeons, the Society for Cardiothoracic Surgery in Great Britain and Ireland, the British Thoracic Society, the British Thoracic Oncology Group, the International Association for the Study of Lung Cancer and the International Mesothelioma Interest Group.

    More about Thoracic Surgery at London Bridge Hosptial

  • Dr Rohit Lal, MRCP PhD, Consultant Medical Oncologist

    Dr Rohit Lal graduated from Guy’s and St Thomas’ United Medical and Dental Schools, London in 1994. He completed his medical rotation in Leeds working in oncology and then undertook formal oncology training at the Royal Marsden Hospitals, London and Sutton.

    Dr Lal was awarded a PhD by the University of London for cancer research at the London Research Institute in 2006. He joined the Medical Oncology department at Guy’s in 2007 with a special interest in thoracic malignancies and clinical trials with new drugs and vaccines.

    At Guy’s, he is the Chair of the Clinical Governance Committee for Oncology and Training Programme Director for medical oncology. He is the national lead for advanced stage thymoma.

  • Dr David Landau, MRCP, FRCR Consultant Clinical Oncologist

    Dr David Landau

    Dr David Landau is a Consultant Clinical Oncologist based at Guys and St Thomas NHS Trust, specialising in radiotherapy and chemotherapy for lung cancer and mesothelioma.

    Having set up one the UK’s only multidisciplinary mesothelioma clinics at Guys Hospital he also has a track record of clinical and scientific research in lung cancer, running national multicentre trials in chemoradiation, in addition to expertise in conventional and IMRT radiotherapy,

    Dr Landau is fully qualified in the Cyberknife stereotactic radiosugery technique which is currently undertaken at The HCA Cyberknife Centre in Harley Street. He is a member of the NCRI (National Cancer Research Institute) subgroups for lung cancer and radiotherapy clinical trials.

    More about Thoracic Surgery at London Bridge Hosptial

  • Dr James Spicer, MRCP, PhD, MB, BS, BA Biochemistry Reader and Honorary Consultant
    in Medical Oncology

    Dr James Spicer

    Dr James Spicer is Senior Lecturer in the Cancer Studies Division of King’s College London, and Honorary Consultant in Medical Oncology at Guy’s and St Thomas’ Hospitals. He trained at major London teaching hospitals, has a PhD in cancer biology from the Institute of Cancer Research in London, and a degree in biochemistry from the University of Oxford.

    Dr Spicer’s clinical and research interests include early phase trials, and novel therapies for lung cancer and other thoracic malignancies. He has established a phase I programme in solid tumour oncology at Guy’s Hospital, and is lead for thoracic medical oncology. He was promoted to reader in experimental oncology, King’s College, London in 2013.

    Dr Spicer was awarded the UK Association of Cancer Physicians McElwain Prize in 2004.

    Cancer Services at London Bridge Hospital